{"resourceType":"ValueSet","id":"2.16.840.1.113762.1.4.1110.39","meta":{"versionId":"11","lastUpdated":"2021-03-17T16:37:33.000-04:00","profile":["http://hl7.org/fhir/StructureDefinition/shareablevalueset","http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"]},"extension":[{"url":"http://hl7.org/fhir/StructureDefinition/valueset-author","valueString":"TJC EH Author"},{"url":"http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate","valueDate":"2022-12-15"},{"url":"http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate","valueDate":"2021-03-17"}],"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.39","identifier":[{"system":"urn:ietf:rfc:3986","value":"urn:oid:2.16.840.1.113762.1.4.1110.39"}],"version":"20210220","name":"TicagrelorTherapy","title":"Ticagrelor Therapy","status":"active","experimental":false,"date":"2021-02-20T01:02:00-05:00","publisher":"TJC EH Steward","jurisdiction":[{"coding":[{"system":"urn:iso:std:iso:3166","code":"US"}]}],"purpose":"(Clinical Focus: The purpose of this value set is to represent concepts for the medication of ticagrelor in therapy used to reduce stroke mortality and morbidity.),(Data Element Scope: This value set may use a model element related to Medication.),(Inclusion Criteria: Includes concepts that represent a medication for ticagrelor therapy.),(Exclusion Criteria: No exclusions.)","compose":{"include":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","concept":[{"code":"1116635","display":"ticagrelor 90 MG Oral Tablet"},{"code":"1666332","display":"ticagrelor 60 MG Oral Tablet"}]}]},"expansion":{"identifier":"urn:uuid:e09e5e51-83b2-4021-beaf-6efe34829340","timestamp":"2023-12-10T21:29:08-05:00","total":2,"contains":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"1116635","display":"ticagrelor 90 MG Oral Tablet"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"1666332","display":"ticagrelor 60 MG Oral Tablet"}]}}